Hengkang Medical Group Co.Ltd(002219)
Securities abbreviation: ST Hengkang securities code: Hengkang Medical Group Co.Ltd(002219) Announcement No.: 2022020 Hengkang Medical Group Co.Ltd(002219) Manager
Warning on the risk that the company’s shares may be subject to superimposed delisting
Suggestive announcement (second time)
The manager of the company, the company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and there are no false records, misleading statements or major omissions.
Hengkang Medical Group Co.Ltd(002219) (hereinafter referred to as “the company”) expects the net assets to be negative at the end of 2021. According to the relevant provisions of articles 9.3.1 and 9.3.2 of the Listing Rules of Shenzhen Stock Exchange (revised in 2022) (hereinafter referred to as the Listing Rules), the company’s shares may be subject to a superimposed delisting risk warning after the disclosure of the 2021 annual report. On January 29, 2022, the company disclosed the suggestive announcement on the warning of the risk of superimposed delisting of the company’s shares (Announcement No.: 2022013), and now the relevant risks are as follows:
1、 Reasons for possible implementation of superimposed delisting risk warning
(I) according to the calculation of the financial department, the net assets of the Company attributable to the shareholders of the listed company at the end of 2021 are expected to be – 22 million yuan to – 290 million yuan. For details, see the manager’s announcement on the performance of 2021 (Announcement No.: 2022012) disclosed on the same day.
(II) according to the relevant provisions of articles 9.3.1 and 9.3.2 of the listing rules, the company’s shares may be subject to a superimposed delisting risk warning after the disclosure of the 2021 annual report.
2、 Other matters
At present, the scheduled disclosure date of the company’s 2021 annual report is April 30, 2022. The audit of the company’s 2021 annual report is in progress. The above forecast data is only the preliminary accounting data of the financial department. At present, the manager is coordinating all parties to actively promote the reorganization process. The progress of the reorganization process will have a significant impact on the amount of net assets. The specific and accurate financial data shall be subject to the audited 2021 annual report officially disclosed by the company. Please pay attention to relevant announcements, make prudent decisions and pay attention to investment risks.
It is hereby announced.
Hengkang Medical Group Co.Ltd(002219)
Hengkang Medical Group Co.Ltd(002219) Manager
March 1, 2002
